STOCK BASED COMPENSATION (Tables)

12 Months Ended

Jan. 01, 2022

Share-based Payment Arrangement [Abstract]

Summary of PBRSs, RSUs, RSAs, and DSUs

Stock-based activity, excluding options, for the year ended January 1, 2022 is summarized below (in thousands, except per share data):

	Performance-Based Restricted Stock Awards			Restricted Stock Units, Restricted Stock Awards, and Deferred Stock Units
	Number of PBRSs	Weighted Average Grant Date Fair Value		Number of RSUs, RSAs, and DSUs	Weighted Average Grant Date Fair Value
Nonvested, January 2, 2021	146	$	32.84	473	$	30.99
Granted	81	79.66		244	78.65
Vested/released	—	—		(233)	30.71
Forfeited/expired	(17)	60.71		(51)	51.81
Nonvested, January 1, 2022	210	$	48.64	433	$	55.54

The following table summarizes additional information about PBRSs, RSUs, RSAs, and DSUs (in thousands, except per share data):

	Fiscal Year Ended (1)
	January 1, 2022		January 2, 2021		December 28, 2019
Weighted average grant date fair value per share of awards granted	$	79.06	$	33.58	$	23.72
Total grant date fair value of awards vested(2)	$	7,145	$	3,215	$	168
Intrinsic value of awards vested(2)	$	19,346	$	5,271	$	345

_________________________________________

(1)Excludes performance-based RSUs activity. See below for further discussion.

(2)Excludes approximately 14,000, 10,500, and 13,000 DSUs that vested but were not released in 2021, 2020, and 2019, respectively.

Summary of Assumptions Utilized to Calculate Fair Value of Stock Options Granted

The following assumptions were utilized to calculate the fair value of stock options granted during the periods indicated below:

	2019
Expected option term	6 years
Expected stock price volatility	27% - 35%
Risk-free interest rate	1.64% - 2.53%
Expected dividend yield	–%
Weighted average fair value at date of grant	$7.67

Summary of Stock Options

A summary of the stock options is as follows for the periods indicated (in thousands, except per share data):

	Number of Options	Weighted Average Exercise Price		Weighted Average Remaining Contractual Term (Years)	Aggregate Intrinsic Value
Balance, December 29, 2018	2,889	$	6.56	6.48
Granted	601	23.59
Exercised	(1,730)	2.06
Forfeited/cancelled	(142)	20.88
Balance, December 28, 2019	1,618	$	16.44	8.12
Exercised	(247)	12.23
Forfeited/cancelled	(117)	21.56
Balance, January 2, 2021	1,254	$	16.79	7.22
Exercised	(408)	10.03
Balance, January 1, 2022	846	$	20.05	6.93	$	53,062
Exercisable, January 1, 2022	609	$	20.06	6.92	$	38,223

Summary of Non-Vested Stock Options

The following is a summary of our non-vested stock options for the periods indicated (in thousands, except per share data):

	Shares Under Outstanding Options	Weighted Average Grant Date Fair Value
Non-vested options at January 2, 2021	539	$	7.44
Granted	—	—
Forfeited	—	—
Vested	(302)	7.41
Non-vested options at January 1, 2022	237	$	7.48